Abstract
ObjectivesTo examine the socioeconomic and demographic drivers associated with polypharmacy (5–9 medicines), extreme polypharmacy (9–20 medicines) and increased medication count.Design, setting and participantsA total of 5509 participants, from two waves...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have